Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA. - Wikidata - wikimedia - TriplyDB

Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA.

Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA.

http://www.wikidata.org/entity/Q34125112

about

Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.Alternative Splicing of G Protein-Coupled Receptors: Relevance to Pain Management.Supraspinal inhibitory effects of chimeric peptide MCRT on gastrointestinal motility in mice.Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.Recent advances in understanding and managing cancer pain

P2860

Q28275620-D57DAE9E-BAAF-4D92-95FA-8DD374068FBC Q36040286-5C1A99AA-E518-4398-A081-777276324586 Q36770675-62DE43D6-6BD4-4F3D-A065-A789517AB0B5 Q37258385-EEE43EB4-C2BC-4BF1-9C07-D3C3D522C41F Q39154155-8EEBDA02-9E39-4ADD-A4CD-6019A2C45F4C Q39371102-25604DE2-7682-4D79-B04E-6D41E403E686 Q39424734-71EE566C-E877-4611-9D46-CECE57B4850C

P2860

Pharmacologic characterization in the rat of a potent analgesic lacking respiratory depression, IBNtxA.

http://www.wikidata.org/entity/Q34125112

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@ast

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@en

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@nl

type

label

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@ast

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@en

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@nl

prefLabel

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@ast

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@en

Pharmacologic characterization ...... espiratory depression, IBNtxA.

@nl

P1433

Q34125112-34A0F835-5124-4963-9FDD-B2DAD8C0AB83

P1476

Q34125112-B2C55A6E-6889-4EE7-889D-9B5A854930E1

P2093

Q34125112-4F6A8F5B-539E-4839-97E9-7E67FF270842

Q34125112-660AD397-8FBD-4F7B-97CD-C30CD7364E8E

Q34125112-82AD3D25-52D5-4E0B-9F9F-D376370B0655

Q34125112-9CD702C3-7A14-46EA-8F82-97144C92DEA7

Q34125112-BEA1B7B3-A881-4F41-A4A0-DEA7DBBB7BF3

Q34125112-ED428656-5033-4F71-B370-E8F15D0DB9BA

P2860

Q34125112-0032D7FA-9868-46C4-9A77-A60FAFD51C6E

Q34125112-00365670-98C7-4D4E-8662-C531E6645656

Q34125112-049D53D3-9D77-45B2-B1B4-D7736C95ACF7

Q34125112-059D2AC2-62D7-4621-B92E-35403F6E2DBF

Q34125112-0683DF0F-CA6E-4C65-B4DB-1C9B3F73FF58

Q34125112-1A4D9CB9-45B5-4072-AD4B-27B435EBBF4C

Q34125112-284E8858-CF40-43EA-9830-6C25BCED3DCE

Q34125112-2CC3F1C3-984A-405B-BBB5-9412E76CCE53

Q34125112-2FE34621-F921-4ED5-AEBC-1AD6581A53CD

Q34125112-3242B1FA-A86A-4B76-BEDB-06C08DA0D76E

P304

Q34125112-A4AF236C-1273-439C-86BD-B2A5FB2BC2F0

P31

Q34125112-FF2F43A3-5543-422C-9BE5-16DF65367F70

P356

Q34125112-44E137D2-30F6-4E0C-A71F-5544098EB70A

P407

Q34125112-D1C9FC6B-AAE2-40AF-979B-8BBA25FCFF5C

P433

Q34125112-8A039612-B379-4F41-8804-439D71EB7D6C

P478

Q34125112-40E2D05D-52E1-4EA4-AC3C-30B492327FA0

P50

Q34125112-0F2B004F-53A6-477A-9B0D-B904FAABF60B

P577

Q34125112-124D2796-7ADD-4673-8FB3-0B2FB86465DD

P5875

Q34125112-4054112F-138B-4882-99AD-E8C501F52EFC

P698

Q34125112-D86BF496-61D1-432A-8692-F8A04100F948

P932

Q34125112-99C362D2-42DB-4DCA-BDA0-A843E5BA36A6

P356

JPET.114.213199

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Pharmacologic characterization ...... respiratory depression, IBNtxA

@en

P2093

Ankita Narayan

http://www.w3.org/2001/XMLSchema#string

Gavril W Pasternak

http://www.w3.org/2001/XMLSchema#string

John E Pintar

http://www.w3.org/2001/XMLSchema#string

Michael Ansonoff

http://www.w3.org/2001/XMLSchema#string

Susruta Majumdar

http://www.w3.org/2001/XMLSchema#string

Valerie Le Rouzic

http://www.w3.org/2001/XMLSchema#string

P2860

G-protein-coupled receptor heterodimerization modulates receptor function

Characterization and visualization of rat and guinea pig brain kappa opioid receptors: evidence for kappa 1 and kappa 2 opioid receptors

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene

Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy

Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene.

Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells.

Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene.

Naloxonazine actions in vivo.

N-naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/kappa-opioid heteromers

P304

710-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.114.213199

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P50

Steven G Grinnell

P577

2014-06-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514756

http://www.w3.org/2001/XMLSchema#string

P698

24970924

http://www.w3.org/2001/XMLSchema#string

P932

4152881

http://www.w3.org/2001/XMLSchema#string